封面
市場調查報告書
商品編碼
1197384

腹腔鏡設備市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Laparoscopy Devices Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內,腹腔鏡設備市場預計將以 7.9% 的複合年增長率增長。

在 COVID-19 大流行期間,世界各地的醫院都實行了社交距離措施,並減少了擇期和非緊急病例,以避免傳播病毒。 然而,緊急婦科和癌症手術正在進行中,確保所有劇院工作人員的安全和 SARS-CoV-2 病毒在對無症狀或確診的 COVID-19 患者進行手術時。將感染風險降至最低非常重要 例如,2020 年 3 月,沙特國家癌症研究所 (SANCI) 發布了護理人員和癌症設施指南,以減少 COVID-19 對癌症患者的影響。 COVID-19 大流行對該地區的泌尿外科實踐和泌尿科醫生招聘產生了重大影響。 由於大流行期間對醫療保健系統的特殊影響,泌尿外科實踐正在發生變化。 2020 年發表在 Dove Press 上的一項研究發現,在大流行期間,泌尿科護理的延誤有所增加,導致門診等待八週。 然而,隨著 COVID 病例開始下降,手術開始恢復到 COVID 之前的水平。

推動市場增長的因素包括技術進步、慢性病流行以及對微創手術的需求增加。 微創手術 (MIS) 引起的術後疼痛較少,因此患者需要的止痛藥較少。 另外,由於切口和縫線很少,住院時間也比較短,不需要經常去醫院就診。

傳統的剖腹手術需要在肌肉上做一個長切口,這需要很長時間才能恢復。 由於恢復時間相對較短,這種手術在老年人中被廣泛接受。 美國婦科腹腔鏡醫師協會 (AAGL) 和國際婦科內鏡醫師協會 (ISGE) 等多個組織正在與南非醫療機構合作,以提高人們對 MIS 益處的認識並提高采用率。我們正在努力改進.

慢性病的增加增加了對更好治療方案的需求。 因此,慢性病患者的數量預計將推動手術數量的增加,從而有助於一次性腹腔鏡設備的增長。 例如,根據世界衛生組織公佈的數據(2021年),全球死亡人數分別為心血管疾病(1790萬)、癌症(930萬)、呼吸系統疾病(410萬)和糖尿病(410萬)1.5百萬)。

因此,與微創手術相關的好處正在推高采用率,這可能會在預測期內進一步推動整個市場的增長。

腹腔鏡設備市場趨勢

減肥手術有望在應用領域佔有重要的市場份額

減肥手術或減肥手術是治療肥胖症的主要治療方法之一。 在這種手術中,胃的一部分被切除或使用胃束帶來縮小胃的大小。 世界範圍內兒童和青少年的肥胖率不斷上升,導致一些年輕患者接受了減肥手術。

越來越多的減肥手術可能會增加對一次性腹腔鏡設備的需求。 例如,根據 Ergie P.Inocian 等人於 2021 年 6 月發表在《肥胖及相關疾病外科雜誌》上的一項研究,中東為解決肥胖和代謝紊亂問題而進行的減肥手術數量正在增加。 因此,減肥手術繼續被中東和北非地區接受為治療嚴重肥胖症的方法,預計將對市場增長產生積極影響。

根據世界衛生組織 (WHO) 的數據,到 2021 年,全球肥胖人數將是 1975 年的近兩倍。 同期,5-19 歲年齡組的肥胖率從 <1% 增加到 7%。 世界衛生組織說,世界上大多數人生活在超重或肥胖致死人數多於體重不足致死的國家。 減肥手術通過限制胃能容納的食物量來減輕體重,導致營養吸收不良,或胃限制和吸收不良的結合。 與減肥手術一樣,腹腔鏡減肥手術對老年人來說是安全的。

北美主導市場,預計在預測期內將繼續佔據主導地位

北美預計將主導全球腹腔鏡設備市場。 該地區的高速增長是由肥胖病例增加、各種慢性病和越來越多地採用微創手術推動的。

根據美國疾病控制與預防中心於 2021 年 4 月更新的一篇文章,十分之六的美國成年人至少患有一種慢性病,十分之四的成年人患有兩種慢性病。我患有不止一種慢性病. 因此,國內慢性病的高患病率增加了對微創手術的需求,帶動了腹腔鏡器械市場。

此外,還採用了有機和無機戰略,例如併購以及與主要市場參與者的合作夥伴關係,以加強公司的產品組合併推動市場研究。 此外,市場上推出的幾種產品有望帶來良好的市場增長。 例如,2021 年 6 月,強生醫療器械公司旗下的 Ethicon 宣布推出一種新型先進的雙極能量設備,該設備可提高手術效率,提供更牢固的密封並接觸更多組織。推出 ENSEAL X1 Curved Jaw Tissue Sealer。 該設備適用於結直腸、婦科、減肥和胸外科手術。

微創手術具有創傷小、患者康復時間快、治療費用低等優點,增加了該地區對腹腔鏡設備的需求。 此外,美國現有企業在各種手術設備方面的進步可能會推動北美市場的增長。

腹腔鏡器械市場競爭者分析

全球腹腔鏡設備市場競爭激烈,由許多大型企業組成。 B. Braun Melsungen AG、Boston Scientific Corporation、ConMed Corporation、Johnson & Johnson (Ethicon Inc.)、Karl Storz GmbH &Co.KG、Medtronic PLC (Covidien)、Olympus Corporation、Richard Wolf GmbH、Smith &Nephew PLC、Stryker 等公司公司在腹腔鏡設備市場佔有很大份額。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 技術進步的增加
    • 慢性病患病率
    • 對微創手術的需求不斷增長
  • 市場製約因素
    • 缺乏腹腔鏡手術專業知識
    • 與這些設備相關的高成本
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(市場規模,按價值計算:百萬美元)

  • 產品名稱
    • 能源設備
    • 腹腔鏡
    • 吸引器
    • 手持設備
    • 抽吸和供水設備
    • 其他產品
  • 申請
    • 減肥手術
    • 婦科手術
    • 結腸手術
    • 其他用途
  • 最終用戶
    • 門診中心
    • 醫院和診所
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • ConMed Corporation
    • Johnson & Johnson(Ethicon Inc.)
    • Karl Storz GmbH & Co. KG
    • Medtronic PLC(Covidien)
    • Olympus Corporation
    • Richard Wolf GmbH
    • Smith & Nephew PLC
    • Stryker Corporation

第7章 市場機會今後動向

簡介目錄
Product Code: 66773

The laparoscopy devices market is expected to witness a CAGR of 7.9% during the forecast period.

During the COVID-19 pandemic, hospitals worldwide reduced elective and non-urgent cases to maintain social distancing and avoid transmission of the virus. However, urgent gynecological and cancer procedures were being performed, and it's critical that all theater staff be safeguarded, and the risk of SARS-CoV-2 viral transmission is minimized when operating on asymptomatic or diagnosed COVID-19 patients. For instance, the Saudi Arabia National Cancer Institute (SANCI) issued a guideline for caregivers and cancer facilities in March 2020 to reduce the impact of COVID-19 on cancer patients.​ The COVID-19 pandemic has significantly impacted urological care and urologist recruitment in this region. The urology practice has been changed due to the exceptional impact on the healthcare system during the pandemic. According to a 2020 study published in the Dove Press, an increase in delayed urological services during the pandemic resulted in a wait of 8 weeks in outpatient clinics.​ However, as COVID cases started declining, the number of surgeries performed began returning to the pre-COVID levels.

Certain factors driving the market growth include increasing technological advancements, the growing prevalence of chronic diseases, and the growing demand for minimally-invasive surgery. Minimally-invasive surgeries (MIS) cause less post-operative pain, and hence, patients receive smaller dosages of pain killers. There are minimal cuts or stitches involved, the hospital stay is relatively shorter, and patients need not visit the hospital frequently.

Traditional open surgeries involve long incisions made through the muscles, and these muscles take a considerable amount of time to heal, whereas MIS procedures involve smaller incisions, leading to a quicker recovery. These surgeries have been gaining wider acceptance among the geriatric population due to the relatively shorter recovery time. Few organizations, such as the American Association of Gynecologic Laparoscopists (AAGL) and the International Society of Gynecologic Endoscopy (ISGE), have been collaborating with healthcare agencies in South Africa to create awareness about the benefits of MIS and improve the adoption rate.

The rising prevalence of chronic diseases is driving up the demand for better treatment measures. As a result, the patient pool for chronic diseases is expected to drive the number of surgeries performed, which will aid in the growth of disposable laparoscopy devices.​ For instance, according to data published by World Health Organization, 2021, cardiovascular diseases account for 17.9 million deaths globally, followed by cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million).

Thus, due to the benefits associated with minimally-invasive surgeries, the adoption rate has been increasing, which may further increase the market's overall growth over the forecast period.

Laparoscopy Devices Market Trends

Bariatric Surgery Expected to Hold Significant Market Share in the Application Segment

Bariatric surgery or weight loss surgery is one of the major treatment procedures for treating obesity. During this procedure, the size of the stomach is reduced by either removing some parts of the stomach or using a gastric band. Increasing obesity rates among children and adolescents are being witnessed across the globe, leading to several young patients undergoing bariatric surgery.​

The increasing bariatric surgical procedures are likely to raise the demand for disposable laparoscopic devices. For instance, according to a research study by Ergie P.Inocian et al., published in Surgery for Obesity and Related Diseases Journal June 2021, there has been an increasing volume of bariatric surgeries in the Middle East to address obesity and metabolic disorders. Thus, bariatric surgical procedures continue to gain acceptance as a treatment for severe obesity in the Middle-East and North Africa regions, which is expected to impact market growth positively.​

According to the World Health Organization (WHO), in 2021, across the world, obesity has almost increased three-fold since 1975. In the five-19 age bracket, obesity increased from less than 1% to 7% over the same period. The WHO states that most of the world's population live in countries where being overweight and obese kills more people than being underweight. Bariatric surgical procedures cause weight loss by restricting the amount of food the stomach can hold, causing malabsorption of nutrients, or combining both gastric restriction and malabsorption. Laparoscopic bariatric surgery is safe in the elderly population, similar to bariatric procedures.

North America Dominates the Market and Expected to Continue Dominance in the Forecast Period

North America is anticipated to dominate the laparoscopy devices market globally. The factors attributed to the region's high growth are the increasing cases of obesity, various chronic diseases, and the growing adoption of minimally-invasive surgeries.

According to an article published by the Center for Disease Control and Prevention, updated in April 2021, six in ten adults in the US have at least one chronic disease, and four in ten adults have two or more chronic diseases. Thus, the high prevalence of chronic diseases in the country increases the demand for minimally invasive surgeries, thus, driving the laparoscopy devices market.

In addition, organic and inorganic strategies such as mergers and acquisitions and partnerships with key market players are being adopted to strengthen companies' product portfolios and drive the market studied. Also, several product launches in the market are expected to result in lucrative market growth. For instance, in June 2021, Ethicon, part of the Johnson & Johnson Medical Devices Companies, launched ENSEAL X1 Curved Jaw Tissue Sealer, a new advanced bipolar energy device that increases procedural efficiency and provides stronger sealing and better access to more tissue. The device is indicated for colorectal, gynecological, bariatric surgery, and thoracic procedures.

The advantages of minimally-invasive surgeries, such as less invasiveness, the quick recovery time of patients, and the low cost of treatment, have augmented the demand for laparoscopy devices in the region. Furthermore, advancements in various surgical devices from established players in the US are likely to drive market growth in North America.

Laparoscopy Devices Market Competitor Analysis

The global laparoscopy devices market is highly competitive and consists of a number of major players. Companies, like B. Braun Melsungen AG, Boston Scientific Corporation, ConMed Corporation, Johnson & Johnson (Ethicon Inc.), Karl Storz GmbH & Co.KG, Medtronic PLC (Covidien), Olympus Corporation, Richard Wolf GmbH, Smith & Nephew PLC, and Stryker Corporation, among others, hold a substantial share in the laparoscopy devices market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Technological Advancements
    • 4.2.2 Growing Prevalence of Chronic Diseases
    • 4.2.3 Growing Demand for Minimally-Invasive Surgery
  • 4.3 Market Restraints
    • 4.3.1 Lack of Expertise in Laparoscopic Surgeries
    • 4.3.2 High Costs Associated with these Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 Product
    • 5.1.1 Energy Devices
    • 5.1.2 Laparoscopes
    • 5.1.3 Insufflation Devices
    • 5.1.4 Handheld Instruments
    • 5.1.5 Suction/Irrigation Devices
    • 5.1.6 Other Products
  • 5.2 Application
    • 5.2.1 Bariatric Surgery
    • 5.2.2 Gynecological Surgery
    • 5.2.3 Colorectal Surgery
    • 5.2.4 Other Applications
  • 5.3 End User
    • 5.3.1 Ambulatory Centers
    • 5.3.2 Hospitals and Clinics
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen AG
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 ConMed Corporation
    • 6.1.4 Johnson & Johnson (Ethicon Inc.)
    • 6.1.5 Karl Storz GmbH & Co. KG
    • 6.1.6 Medtronic PLC (Covidien)
    • 6.1.7 Olympus Corporation
    • 6.1.8 Richard Wolf GmbH
    • 6.1.9 Smith & Nephew PLC
    • 6.1.10 Stryker Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS